Page 5 - SAMRC Annual Performance Plan 2026-27

9.3.4 The Executive Management Committee ........................................................................................................... 31
9.3.5 People Management.......................................................................................................................................... 31
9.3.6 Transformation.................................................................................................................................................... 37
9.3.7 International Partnership for Building a Vaccine R&D and Manufacturing Workforce for Africa the CSSFF-
SAMRC Capacity Development Programme ..................................................................................................... 38
9.3.8 Investing in Human Capital Development and Capacity in Health Care: Bongani Mayosi National Health
Scholars Programme .......................................................................................................................................... 38
9.3.9 Research Integrity and Ethical Conduct............................................................................................................. 38
9.3.10 Publication in Open Access journals.................................................................................................................. 39
9.3.11 Funding Research............................................................................................................................................... 39
9.3.12 Support for the South African National Health Research Enterprise in Response to USA Funding
Withdrawals........................................................................................................................................................ 39
9.3.13 Data Processing.................................................................................................................................................. 41
9.3.14 Research Support ............................................................................................................................................... 41
9.3.15 Communication .................................................................................................................................................. 41
9.3.16 Risk Management............................................................................................................................................... 41
9.3.17 Internal Audit and Audit Committee ................................................................................................................. 42
9.3.18 Managing Conflicts of Interest........................................................................................................................... 42
9.3.19 Governance ........................................................................................................................................................ 42
9.3.20 B-BBEE Compliance Performance Information.................................................................................................. 42
9.3.21 SAMRC Intramural and Extramural research units, and Platforms.................................................................... 43
9.3.22 Formation of the SAMRC foundation ................................................................................................................ 51
9.3.23 Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis............................................................. 53
9.3.24 Political Economic Social Technology Environmental and Legal (PESTEL) Analysis.......................................... 54

PART C: MEASURING SAMRC PERFORMANCE......................................................................................................56
10 Institutional Programme Performance Information....................................................................................................... 57

10.1 Programme 1: Administer health research effectively and efficiently, and in accordance with good
corporate governance practices ........................................................................................................................ 57
10.2 Programme 2: Lead the generation of new knowledge and funding of research ........................................... 58
10.3 Programme 3: Supporting health innovation and technology development through funding to improve
health.................................................................................................................................................................. 59
10.4 Programme 4: Building sustainable health research human capacity in South Africa ..................................... 60
10.5 Programme 5: Research Translation into policy and practice to improve health............................................. 62
11 Explanation of planned performance over the medium-term period........................................................................... 63
12 Programme Resource Considerations (R’000) ............................................................................................................... 63
13 Budget............................................................................................................................................................................ 66
14 Key Risks which may affect achievement of the outcomes........................................................................................... 68
15 Public Entity Description................................................................................................................................................ 70
16 Infrastructure Projects.................................................................................................................................................... 70
17 Public Private Partnerships ............................................................................................................................................ 70

PART D: TECHNICAL INDICATOR DESCRIPTIONS..................................................................................................72
Annexure A: Consolidated Indicators.................................................................................................................................. 82
Annexure B: SAMRC’s Materiality and Significance Framework 2025/26 .......................................................................... 86
Annexure C: Acronyms ........................................................................................................................................................ 90

SAMRC ANNUAL PERFORMANCE PLAN 2026/27 3